T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
58 hedge funds and large institutions have $3.12M invested in T2 Biosystems, Inc in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 10 closing their positions.
100% more call options, than puts
Call options by funds: $40K | Put options by funds: $20K
13% less funds holding
Funds holding: 67 → 58 (-9)
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
61% less capital invested
Capital invested by funds: $8.02M → $3.12M (-$4.9M)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.2M |
| 2 |
VF
Virtu Financial
New York
|
+$91.9K |
| 3 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
+$53.4K |
| 4 |
Charles Schwab
San Francisco,
California
|
+$50.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$23.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$104K |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
-$93K |
| 3 |
Franklin Resources
San Mateo,
California
|
-$37.1K |
| 4 |
Morgan Stanley
New York
|
-$20.7K |
| 5 |
HF
HRT Financial
New York
|
-$18K |
TTOO Hedge Fund Activity: Q2 2022 in Review
58 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2022, worth a combined $3.12M — down 61% from $8.02M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TTOO and 3 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 6 added.
The largest buyer was Vanguard Group, adding an estimated $1.2M. The largest seller was BlackRock, cutting an estimated $104K.
- 58 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2022, down from 67 in Q1 2022.
- Funds reported $3.12M of T2 Biosystems, Inc stock for Q2 2022, down 61% quarter-over-quarter.
- 3 funds opened new T2 Biosystems, Inc positions in Q2 2022 and 10 closed out, a net change of -7 holders.
- The largest T2 Biosystems, Inc buyer in Q2 2022 was Vanguard Group, an estimated $1.2M added.
- The largest T2 Biosystems, Inc seller in Q2 2022 was BlackRock, an estimated $104K sold.
Based on aggregated 13F filings for Q2 2022.